TOKYO, (December 27, 2022)—Evident Co., Ltd (“Evident”) announces the postponement of the transfer of all shares of Evident Corporation from Olympus Corporation (“Olympus”) to K.K. BCJ-66, a special purpose company indirectly owned by funds advised by Bain Capital Private Equity, LP (together with its affiliates, “Bain Capital”).

Reasons for the postponement

The transfer, originally planned for January 4, 2023—as announced on August 29, 2022—is subject to certain conditions, including Bain Capital’s receipt of approval(s) from relevant authorities pursuant to the competition laws and foreign investment policy applications. However, due to delays in competition law procedures in some countries, conditions for the transfer of shares are not expected to be satisfied by January 4, 2023. Therefore, Olympus and Bain Capital have decided to postpone the transfer date to Feb 2023. We will promptly make an announcement regarding any future steps once they have been finalized.

We will update the News section of EvidentScientific.com with any further information related to the transfer of all shares of Evident Corporation from Olympus to Bain Capital.

Link to the Olympus' announcement.

About EVIDENT

In 2022, Olympus Corporation spun off its Scientific Solutions Division, which included its life science and industrial solutions businesses, to establish a new company called Evident. Although our name is different, our expertise, manufacturing capabilities, and commitment to our customers, which defined us over the past 100 years, remain unchanged.

At Evident, innovation and exploration are at the heart of what we do. Committed to making people’s lives healthier, safer, and more fulfilling, we support our customers with solutions that solve their challenges and advance their work; whether it’s researching medical breakthroughs, inspecting infrastructure, or exposing hidden toxins in consumer products.

Evident’s industrial solutions range from microscopes and videoscopes to nondestructive testing equipment and X-ray analyzers for maintenance, manufacturing, and environmental applications. Backed by state-of-the-art technologies, Evident products are widely used for quality control, inspection, and measurement.

In life science, Evident empowers scientists and researchers through collaboration and cutting-edge solutions. We’re dedicated to meeting the challenges and supporting the evolving needs of our customers, continuing to advance a comprehensive range of microscopes for pathology, hematology, IVF, and other clinical applications as well as for research and education.

For more information, visit EvidentScientific.com.